U.S. markets close in 2 hours 47 minutes

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
134.48-2.11 (-1.54%)
As of 1:12PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Symmetrical Continuation Triangle (Bearish)

Symmetrical Continuation Triangle (Bearish)

Previous Close136.59
Bid134.07 x 1000
Ask134.36 x 800
Day's Range130.49 - 137.45
52 Week Range58.38 - 151.97
Avg. Volume1,560,500
Market Cap45.459B
Beta (5Y Monthly)1.40
PE Ratio (TTM)13.88
EPS (TTM)9.69
Earnings DateOct 26, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 28, 2020
1y Target Est149.95
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
10% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • TheStreet.com

    HCA Healthcare Shares Are Volatile on Mixed Q3 Results

    HCA Healthcare reported mixed third-quarter results after pre-reporting strong revenue two weeks ago.

  • HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y

    HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y

    HCA Healthcare's (HCA) third-quarter results reflect decline in admissions, partly offset by higher revenues.

  • MarketWatch

    HCA Healthcare stock drops after profit comes up shy of expectations, but revenue beats forecasts

    Shares of HCA Healthcare Inc. sank 3.6% in premarket trading Monday, after the hospital operator reported a third-quarter profit that came up short of expectations, while revenue rose above forecasts despite a drop in same-facility admissions. Net income rose to $668 million, or $1.95 a share, from $612 million, or $1.76 a share, in the year-ago period. the company said the results include a reversal of $822 million, or $1.72 a share, in government stimulus income recorded in the sequential second quarter. The FactSet consensus for earnings per share was $2.32, and the consensus for net EPS was $2.61. Revenue increased 4.9% to $13.31 billion, above the FactSet consensus of $12.90 billion. Same-facility admissions declined 3.8% and equivalent admissions fell 9.0%, as same-facility emergency room visits dropped 20.3% and same-facility inpatient surgeries declined 6.8%. Meanwhile, same-facility revenue per equivalent admission increased 14.8%, due to increases in acuity of patients treated and favorable payer mix. The stock has lost 7.6% year to date through Friday, while the SPDR Health Care Select Sector ETF has gained 5.9% and the S&P 500 has advanced 7.3%.